TSMRF (TSMRF) Stock Price & Analysis

TSMRF (TSMRF) rose 0.00% to USD 23.2 as of June 10, 2026 at 03:44 UTC, according to Nexqual real-time market data.

TSMRF last closed at USD 23.2; the session ranged USD 28.15–28.15 on volume of 100 shares. Market capitalization is $1.73B, with a 52-week range of USD 23.2–28.15 (PNK). Source: Nexqual, June 10, 2026 at 03:44 UTC.

Key Statistics (as of June 10, 2026 at 03:44 UTC)

PriceUSD 23.2
Change▲ 0.00% (up)
Previous CloseUSD 23.2
OpenUSD 28.15
Day RangeUSD 28.15 – 28.15
52-Week RangeUSD 23.2 – 28.15
Volume100 shares
Market Cap$1.73B
ExchangePNK

Technical Analysis (TSMRF)

Nexqual's technical model rates TSMRF "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 03:44 UTC.

Overall SignalBUY
RSI (14)100 (overbought)
vs SMA50Below (USD 23.2)
MACD0 (negative)

Analyst Ratings (TSMRF)

Wall Street analysts rate TSMRF "None", per Nexqual as of June 10, 2026 at 03:44 UTC.

Consensus RatingNone

Earnings (TSMRF)

Next Earnings Date2026-08-06
Revenue Estimate$49.84B

Source: Nexqual, June 10, 2026 at 03:44 UTC.

Financials & Fundamentals (TSMRF)

Total Revenue$192.62B
Revenue Growth (YoY)+7.00%
Gross Margin+47.51%
Operating Margin+13.40%
Profit Margin+14.60%
ROE+8.62%
Debt / Equity36.37
Current Ratio4.19
Total Cash$84.08B
Total Debt$135.16B
Free Cash Flow$-28.69B

Source: Nexqual, June 10, 2026 at 03:44 UTC.

Financial Health Score (TSMRF)

Nexqual rates TSMRF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:44 UTC.

GrowthSolid — Revenue +6% YoY (annual)
ProfitabilityStrong — Gross margin 48%, operating 13%
Balance SheetStrong — $84.1B cash vs $135.2B debt
Cash FlowWeak — FCF negative: -$28.7B, burning cash
EfficiencyMixed — ROE 9%, ROA 4.2%

Ownership (TSMRF)

Insider Ownership+8.37%
Institutional Ownership+51.10%
Shares Outstanding74.55M
Float63.63M

Source: Nexqual, June 10, 2026 at 03:44 UTC.

Leadership (TSMRF)

TSMRF is led by Terukazu Kato (age 62), President, CEO & Chairman, per Nexqual as of June 10, 2026 at 03:44 UTC.

President, CEO & ChairmanTerukazu Kato (age 62)
CFO & Head of the Corporate Management DivisionKaoru Kobayashi
COO & DirectorKei Sugii (age 56)
CTO and Head of Research & Development DivisionAkihito Konda
Executive Officer & Chinese Herbal Medicine Platform DirectorYoshiharu Watanabe

Major Backers & Investors (TSMRF)

Notable institutional backers of TSMRF include Goldman Sachs, Victory Portfolios-Victory Trivalent International Small-Cap Fund, DFA INVESTMENT TRUST CO-The Japanese Small Company Series, according to Nexqual as of June 10, 2026 at 03:44 UTC.

Active Investors

InvestorStake
Goldman Sachs1.13%
Victory Portfolios-Victory Trivalent International Small-Cap Fund0.71%
DFA INVESTMENT TRUST CO-The Japanese Small Company Series0.64%
Bridge Builder Trust-Bridge Builder International Equity Fund0.58%
HARBOR FUNDS-Harbor International Fund0.48%

Index Funds (Passive)

FundStake
Vanguard Group2.1%
BlackRock0.86%

Source: Nexqual, June 10, 2026 at 03:44 UTC.

Peers & Related Stocks

SymbolNamePriceChange
TINLFTEIJIN LTDUSD 9.51▲ 0%
62715.HK62715.HKHKD 0.46▲ 1.11%
300857.SZSHARETRONIC DATA TECHNOLOGY CO CNY 220.8▼ 0.32%
MURGFMuenchener Rueckver GesUSD 516▲ 1.61%
UNCFFUniCredito SpaUSD 83▼ 3.14%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:44 UTC. This page is informational and not investment advice.